RGD peptide matrix vs placebo
Adverse events · individuals with sickle cell disease and a leg ulcer
It is very uncertain whether RGD peptide matrix changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
- Interventions for treating leg ulcers in people with sickle cell disease 2021 · Cochrane Headline outcomes onlyRR 0.76 [0.5, 1.17]1 study · 55 participantsVery low